retatrutide phase 2 trial obesity triple agonist for diabetes type hormone receptor metabolic dysfunction-associated steatotic liver disease: a randomized 2a Retatrutide is gaining attention in – Retatrutide Phase 2 NEJM Trial:

Its no surprise then that Hall recommends regular strength training to her patients on GLP-1s

doi: New Jersey Bariatric Center Opens New Location in Bridgewater, NJ Office to Serve Bariatric Surgery and Medical Weight Loss Patients in Somerset, Morris, Hunterdon and Middlesex County SPRINGFIELD, NJ, February 3, 2026 - New Jersey Bariatric Center (NJBC), a New Jersey leader in medical and surgical weight loss, announces a new office location in Central New Jersey starting March 2, 2026 to serve its growing patient base

SpongeBob has received widespread critical acclaim since its release, with praise given to its characters, surreal humor, writing, visuals, animation, and Hawaiian-influenced soundtrack

Addressing these challenges while capitalizing on innovations in drug design will be essential for optimizing patient outcomes and realizing the full potential of GLP-1based therapies